Literature DB >> 16339812

Similar cardiac remodelling after transcatheter atrial septal defect closure in children and young adults.

G Santoro1, M Pascotto, S Caputo, F Cerrato, M Cappelli Bigazzi, M T Palladino, C Iacono, M Carrozza, M G Russo, R Calabrò.   

Abstract

OBJECTIVE: To study the cardiac geometric changes after transcatheter closure of large atrial septal defects (ASDs) according to patient age at the time of the procedure.
DESIGN: Prospective echocardiographic follow-up study.
SETTING: Tertiary referral centre. PATIENTS AND INTERVENTION: 25 asymptomatic patients younger than 16 years (median 8 years; group 1) and 21 asymptomatic adults (median 38 years; group 2) underwent percutaneous closure of large ASD with the Amplatzer septal occluder device (mean 25 (SD 7) mm). MAIN OUTCOME MEASURES: Cardiac remodelling was assessed by M mode and two dimensional echocardiography one and six months after ASD closure.
RESULTS: By six months, right atrial volume decreased from 31 (15) to 19 (5) ml/m(2) (p < 0.001) and right ventricular (RV) transverse diameter decreased from 29.8 (8.6) to 23.2 (5.6) mm/m(2) (p < 0.001). Conversely, left atrial volume did not change significantly (from 18 (6) to 20 (6) ml/m(2), NS) and left ventricular (LV) transverse diameter increased from 27.8 (6.4) to 31.8 (7.3) mm/m(2) (p < 0.05). Ventricular remodelling resulted in an RV:LV diameter ratio decrease from 1.1 (0.2) to 0.7 (0.1) (p < 0.001). The magnitude and time course of cardiac remodelling did not differ significantly between the age groups. Indeed, right atrial volume decreased by 33 (26)% versus 37 (23)%, RV diameter decreased by 26 (10)% versus 20 (13)%, LV diameter increased by 17 (15)% versus 15 (10)%, and RV:LV diameter ratio decreased by 36 (8)% versus 27 (15)% in groups 1 and 2, respectively.
CONCLUSIONS: Cardiac remodelling after percutaneous ASD closure seems to be independent of the patient's age at the time of the procedure up to early adulthood. Thus, postponing ASD closure for a few years may be a reasonable option for potentially suitable asymptomatic children.

Entities:  

Mesh:

Year:  2005        PMID: 16339812      PMCID: PMC1860715          DOI: 10.1136/hrt.2005.070169

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  32 in total

1.  Speed of normalization of right ventricular volume overload after transcatheter closure of atrial septal defect in children and adults.

Authors:  Z D Du; Q L Cao; P Koenig; M Heitschmidt; Z M Hijazi
Journal:  Am J Cardiol       Date:  2001-12-15       Impact factor: 2.778

2.  Resolution of right heart enlargement after closure of secundum atrial septal defect with transcatheter technique.

Authors:  H W Kort; D T Balzer; M C Johnson
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

3.  Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial.

Authors:  Zhong Dong Du; Ziyad M Hijazi; Charles S Kleinman; Norman H Silverman; Kinley Larntz
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

4.  Increased collagen synthesis and decreased collagen degradation in right ventricular hypertrophy induced by pressure overload.

Authors:  J E Bishop; S Rhodes; G J Laurent; R B Low; W S Stirewalt
Journal:  Cardiovasc Res       Date:  1994-10       Impact factor: 10.787

5.  Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost.

Authors:  J D R Thomson; E H Aburawi; K G Watterson; C Van Doorn; J L Gibbs
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

6.  Treatment of atrial septal defects in symptomatic children aged less than 2 years of age using the Amplatzer septal occluder.

Authors:  M Vogel; F Berger; I Dähnert; P Ewert; P E Lange
Journal:  Cardiol Young       Date:  2000-09       Impact factor: 1.093

7.  Transcatheter closure of atrial septal defects in the oval fossa: is the method applicable in small children?

Authors:  Per G Bjørnstad; Henrik Holmstrøm; Bjarne Smevik; Tor Inge Tønnessen; Erik Fosse
Journal:  Cardiol Young       Date:  2002-07       Impact factor: 1.093

8.  Quantification of regional right and left ventricular function by ultrasonic strain rate and strain indexes after surgical repair of tetralogy of Fallot.

Authors:  Frank Weidemann; Benedicte Eyskens; Luc Mertens; Christoph Dommke; Miroslaw Kowalski; Lisa Simmons; Piet Claus; Bart Bijnens; Marc Gewillig; Liv Hatle; George R Sutherland
Journal:  Am J Cardiol       Date:  2002-07-15       Impact factor: 2.778

9.  Levels of exhaled nitric oxide before and after surgical and transcatheter device closure of atrial septal defects in children.

Authors:  Tilman Humpl; Rosalie Campbell; Derek Stephens; Glen Van Arsdell; Lee N Benson; Helen M Holtby; Arthur S Slutsky; Ian Adatia
Journal:  J Thorac Cardiovasc Surg       Date:  2002-10       Impact factor: 5.209

10.  Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure.

Authors:  Marie-Claude Brochu; Jean-François Baril; Annie Dore; Martin Juneau; Pierre De Guise; Lise-Andrée Mercier
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

View more
  9 in total

1.  Effects of age on hemodynamic changes after transcatheter closure of atrial septal defect: importance of ventricular diastolic function.

Authors:  Satoshi Masutani; Mio Taketazu; Hirotaka Ishido; Yoichi Iwamoto; Shigeki Yoshiba; Tamotsu Matsunaga; Toshiki Kobayashi; Hideaki Senzaki
Journal:  Heart Vessels       Date:  2011-03-18       Impact factor: 2.037

2.  Incomplete RV Remodeling After Transcatheter ASD Closure in Pediatric Age.

Authors:  Hala M Agha; Sonia A El-Saiedi; Mohamed F Shaltout; Hala S Hamza; Hayat H Nassar; Doaa M Abdel-Aziz; Amira Esmat El Tantawy
Journal:  Pediatr Cardiol       Date:  2015-05-17       Impact factor: 1.655

3.  Early and six-month assessment of bi-ventricular functions following surgical closure of atrial septal defect.

Authors:  Rajesh Vijayvergiya; Jiten Singh; Sandeep S Rana; Ranjan Shetty; Bhagwant R Mittal
Journal:  Indian Heart J       Date:  2014-11-10

4.  Transcatheter closure for residual atrial septal defect resulting from surgical patch closure 44 years previously.

Authors:  Hiroki Matsuzoe; Hidekazu Tanaka; Keiko Hatazawa; Yutaka Hatani; Kensuke Matsumoto; Toshiro Shinke; Ken-Ichi Hirata
Journal:  J Echocardiogr       Date:  2018-01-06

Review 5.  Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

Authors:  Charles Stevens Leger; Joseph F X DeSouza
Journal:  Front Neurol       Date:  2017-03-20       Impact factor: 4.003

6.  Effectiveness and Safety of Transcatheter Atrial Septal Defect Closure in Adults with Systemic Essential Hypertension.

Authors:  Iwona Świątkiewicz; Łukasz Bednarczyk; Michał Kasprzak; Ewa Laskowska; Marek Woźnicki
Journal:  J Clin Med       Date:  2022-02-13       Impact factor: 4.241

7.  Functional Echocardiographic and Serum Biomarker Changes Following Surgical and Percutaneous Atrial Septal Defect Closure in Children.

Authors:  Jelle P G van der Ven; Eva van den Bosch; Vivian P Kamphuis; Covadonga Terol; Devi Gnanam; Ad J J C Bogers; Johannes M P J Breur; Rolf M F Berger; Nico A Blom; Laurens Koopman; Arend D J Ten Harkel; Willem A Helbing
Journal:  J Am Heart Assoc       Date:  2022-08-05       Impact factor: 6.106

8.  Latent pulmonary hypertension in atrial septal defect: Dynamic stress echocardiography reveals unapparent pulmonary hypertension and confirms rapid normalisation after ASD closure.

Authors:  S A Lange; M U Braun; S P Schoen; R H Strasser
Journal:  Neth Heart J       Date:  2013-07       Impact factor: 2.380

9.  Biventricular reverse remodeling and relationship with mitral valve prolapse after transcatheter closure of ASD secundum, a 3D echocardiographic study.

Authors:  Amal El-Sisi; Shaheen Dabour; Aya M Fattouh; Effat Assar; Rasha Naguib; Antoine Fakhry AbdelMassih
Journal:  J Cardiovasc Thorac Res       Date:  2019-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.